EC Number   |
Title |
Organism |
|---|
  2.1.1.1 | A rapid and efficient assay for the characterization of substrates and inhibitors of nicotinamide N-methyltransferase |
Homo sapiens |
| 2.1.1.1 | Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance |
Homo sapiens |
| 2.1.1.1 | Bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT) with enhanced activity |
Homo sapiens |
| 2.1.1.1 | Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide |
Macaca mulatta |
| 2.1.1.1 | Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide |
Mus musculus |
| 2.1.1.1 | Discovery of bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT) |
Homo sapiens |
| 2.1.1.1 | High-affinity alkynyl bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT) |
Homo sapiens |
| 2.1.1.1 | Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state |
Homo sapiens |
| 2.1.1.1 | Kinetic mechanism of nicotinamide N-methyltransferase |
Homo sapiens |
| 2.1.1.1 | Nicotinamide N-methyltransferase catalyses the N-methylation of the endogenous beta-carboline norharman evidence for a novel detoxification pathway |
Homo sapiens |
